MX9709234A - Preparacion para el diagnostico del sindrome metabolico y enfermedades que incluyen el sindrome. - Google Patents
Preparacion para el diagnostico del sindrome metabolico y enfermedades que incluyen el sindrome.Info
- Publication number
- MX9709234A MX9709234A MX9709234A MX9709234A MX9709234A MX 9709234 A MX9709234 A MX 9709234A MX 9709234 A MX9709234 A MX 9709234A MX 9709234 A MX9709234 A MX 9709234A MX 9709234 A MX9709234 A MX 9709234A
- Authority
- MX
- Mexico
- Prior art keywords
- syndrome
- metabolic syndrome
- diagnostic
- preparation
- cortisol
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
- A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
- G01N33/743—Steroid hormones
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Molecular Biology (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Urology & Nephrology (AREA)
- General Health & Medical Sciences (AREA)
- Biomedical Technology (AREA)
- Medicinal Chemistry (AREA)
- Hematology (AREA)
- Immunology (AREA)
- Analytical Chemistry (AREA)
- Epidemiology (AREA)
- Food Science & Technology (AREA)
- Cell Biology (AREA)
- Physics & Mathematics (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- Endocrinology (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Pharmacology & Pharmacy (AREA)
- Microbiology (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Steroid Compounds (AREA)
- Combined Controls Of Internal Combustion Engines (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
Se describe uso de agonista de cortisol para preparar un sistema para el diagnostico del síndrome metabolico y condiciones relacionadas como obesidad del vientre, resistencia a la insulina incluyendo el riesgo incrementado de desarrollar diabetes senil, es decir, diabetes de tipo II, un alto contenido de grasa en la sangre y una lata presion sanguínea, en donde el sistema, la dosis del agoniza de coritos está en un intervalo en donde se obtiene una diferencia en el efecto inhibido de la autoproduccion de cortisol en individuos que sufren de síndrome metabolico, comparado con valores normales.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE9501991A SE505391C2 (sv) | 1995-05-30 | 1995-05-30 | Användning av kortisol-agonister för framställning av ett system för diagnostisering av det metabola syndromet |
| SE9501991-5 | 1995-05-30 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| MX9709234A true MX9709234A (es) | 1998-10-31 |
| MXPA97009234A MXPA97009234A (es) | 1999-01-11 |
Family
ID=
Also Published As
| Publication number | Publication date |
|---|---|
| DE69626982T2 (de) | 2004-03-04 |
| NO975492D0 (no) | 1997-11-28 |
| RU2171471C2 (ru) | 2001-07-27 |
| DE69626982D1 (de) | 2003-04-30 |
| EP0835138A1 (en) | 1998-04-15 |
| WO1996038179A1 (en) | 1996-12-05 |
| EP0835138B1 (en) | 2003-03-26 |
| AU716671B2 (en) | 2000-03-02 |
| ES2189872T3 (es) | 2003-07-16 |
| AU5917396A (en) | 1996-12-18 |
| CN1078479C (zh) | 2002-01-30 |
| NO319829B1 (no) | 2005-09-19 |
| ATE235258T1 (de) | 2003-04-15 |
| SE505391C2 (sv) | 1997-08-18 |
| CA2222215A1 (en) | 1996-12-05 |
| CN1185743A (zh) | 1998-06-24 |
| PT835138E (pt) | 2003-08-29 |
| JPH11505850A (ja) | 1999-05-25 |
| NO975492L (no) | 1998-01-27 |
| US6410339B1 (en) | 2002-06-25 |
| SE9501991L (sv) | 1996-12-01 |
| DK0835138T3 (da) | 2003-07-21 |
| BR9608683A (pt) | 1999-12-07 |
| SE9501991D0 (sv) | 1995-05-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU5917396A (en) | Preparation for diagnostic of the metabolic syndrome and diseases including the syndrome | |
| Van Cauter et al. | Demonstration of rapid light-induced advances and delays of the human circadian clock using hormonal phase markers | |
| Parish et al. | Relationship of metabolic syndrome and obstructive sleep apnea | |
| Spiegel et al. | Impact of sleep debt on metabolic and endocrine function | |
| Ravitz et al. | Disturbances of Hypotha1amicPituitary-Adrena1 Axis functioning during ethanol withdrawal in six men | |
| Halbreich et al. | Hypothalamo-pituitary-adrenal activity in endogenously depressed post-traumatic stress disorder patients | |
| Rosenbloom et al. | Chronic overtreatment with insulin in children and adolescents | |
| Haffner et al. | Greater effect of glycemia on incidence of hypertension in women than in men | |
| Lunzer et al. | Skeletal muscle blood flow and neurovascular reactivity in liver disease | |
| RU97121292A (ru) | Препарат для диагностики метаболического синдрома и заболеваний, включающих в себя данный синдром | |
| Svane-Knudsen | Sudden “spontaneous” lesion of aural function | |
| Yamamoto et al. | Psychophysiological study on fasting therapy | |
| Connor | Obesity, hypertension and stroke | |
| Tsai et al. | Computation of respiratory resistance, compliance, and inertance from forced oscillatory impedance data | |
| Del Seppia et al. | Evidence in hypertensive rats of hypotensive effect after mandibular extension | |
| Tarnow et al. | Effects of nisoldipine and lisinopril on left ventricular mass and function in diabetic nephropathy | |
| Kirby et al. | Do" anorectic" drugs produce weight loss by appetite suppression? | |
| Chaturvedi et al. | ACE inhibitors and risk of hypoglycemia in people with diabetes/Response | |
| Davignon et al. | Studies on the in vitro production of corticosteroids by adrenal glands from normotensive individuals and hypertensive patients | |
| Uzunlulu et al. | Is metabolic syndrome a condition independent of prediabetes and type 2 diabetes mellitus? A report from Turkey | |
| Westaway et al. | Management of diabetes mellitus in outpatient facilities is achieving poor results | |
| Oluwatelure | Effect of rational emotive therapy in blood pressure reduction and attitude change among hypertensives | |
| Grof et al. | Neuroendocrine responses as an indicator of recurrence liability in primary affective illness | |
| Newnham et al. | Extrapulmonary β 2-responses to intravenous salbutamol during the menstrual cycle | |
| Okada et al. | Effect of α-glucosidase inhibitor in combination with sulphonylurea compounds on lipid profile in patients with non-insulin-dependent diabetes mellitus |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG | Grant or registration | ||
| MM | Annulment or lapse due to non-payment of fees |